Physician Leaders Discuss the Future of Breast Oncology 

Written by: Maddi Langweil
Medically Reviewed By: Sara Tolaney, MD, MPH and Elizabeth Mittendorf, MD, PhD, MHCM

The Breast Oncology Center at Dana-Farber is leading the future of breast cancer treatment and care through innovation, collaboration, and delivering state-of-the-art patient care. 

As Dana-Farber and Beth Israel Deaconess Medical Center (BIDMC) work in clinical collaboration to improve efficiency, quality, and patient care, Sara Tolaney, MD, MPH, chief of Breast Oncology and associate director of the Susan F. Smith Center for Women’s Cancers and Elizabeth Mittendorf, MD, PhD, MHCM, chief of Multi-Disciplinary Oncology at Dana-Farber and of Breast Surgery in the Department of Surgery at BIDMC, discuss the future of breast cancer research and treatment.    

“This is an extraordinary time for us to continue to move the needle in breast cancer care,” says Tolaney. “We already have an outstanding program, but there is always an opportunity to evolve our program and continue to grow for our patients.” 

How is the program growing to support the needs of patients with breast cancer?  

Tolaney: When we take care of a patient with breast cancer, it is quite complex and requires expertise from clinicians across a range of specialties. At Dana-Farber, the emphasis is on supporting each patient with a multidisciplinary team and making sure care is individualized and comprehensive. We take better care of our patients because we have the right experts in the room to provide breadth and depth of knowledge and perspective.  

Mittendorf: Patients feel the difference when care is personalized to them and with them. Teams are built with intention because we are not just bringing together different specialties, but we’re also creating a care model in which all disciplines support each other. I work closely with leaders across medical oncology, surgery, pathology, radiology, and radiation oncology to envision what our integrated care is going to look like. This includes everything from how we structure our clinics in coordinating care to how we measure success achieving our goals. 

What else might patients expect from this collaboration? 

Mittendorf: Through this collaboration, patients gain access to investigational therapies earlier because of the breadth and depth of the Breast Oncology research program. This helps patients across all disease stages — from early-stage to metastatic disease — which is essential because these efforts help shape future standards of care.  

What else might patients expect from a cancer-leading Institute?  

Mittendorf: We are leveraging our talented experts and the latest innovations to optimize care and provide patients with an unprecedented level of support from screening and diagnosis through treatment into survivorship. For example, we are integrating artificial intelligence in our current imaging infrastructure at BIDMC. This new risk assessment tool called Clairity will provide an individual with their five-year risk of developing breast cancer. It is part of our broader effort to make risk assessments accessible, consistent, accurate, and equitable. We are the first in the country to do this.  

Our technological capabilities are strong, but we are also supporting each patient with the right resources for their care. We have robust support programs for patients in a variety of ways. Patients and their families are embedded in a community that offers integrative care, from nutrition to social work and acupuncture. This is all part of treating the whole patient, not just the cancer itself. 

Why is patient-centered care important to Breast Oncology? 

Tolaney: By integrating the latest therapies and supportive services, we are personalizing care in a way that makes patients feel seen as individuals. Patients and their families are on a journey, and we are on this journey with them. It is not easy and it helps me ensure that we’re doing everything we can to help. Our program integrates compassionate care with access to the latest therapies, advanced research and expertise.  

There are not many places in the world that have this level of thought being put into the care of every person that comes here, even before they’ve walked in the door. It takes a village to care for someone, and that is one of our biggest priorities.  

Leave a Comment